| Field | Detail |
|---|---|
| Legal name | Schroder British Opportunities Trust plc |
| Former names | None identified |
| Profiled entity | Schroder British Opportunities Trust plc (UK investment trust) |
| Founding / launch | Launched (IPO) 1 December 2020 (Schroders corporate-governance page: inception date 1 December 2020) |
| Incorporation jurisdiction | England and Wales; investment company under s.833 Companies Act 2006; approved investment trust under s.1158 Corporation Tax Act 2010 (Annual Report FY2026) |
| Registered office / correspondence address | 1 London Wall Place, London EC2Y 5AU, United Kingdom (Annual Report FY2026, AGM notice) |
| Exchange and ticker | London Stock Exchange, Main Market: SBO (shown on some data vendors as SBO.L) |
| ISIN | GB00BN7JZR28 |
| SEDOL | BN7JZR2 |
| LEI | 5493003UY8LIHFW6HM02 (from ESEF filing identifier) |
| CUSIP | Not applicable / not publicly disclosed |
| Share class | Ordinary shares of 1p |
| Shares in issue | 73,900,000 excluding treasury; 1,100,000 held in treasury (Annual Report FY2026) |
| Fiscal year end | 31 March (changed from 30 June with effect from 1 July 2021; the FY2022 period was nine months) |
| Employees | Nil. The company has no employees; all functions outsourced (Annual Report FY2026). 3-year trend: 0 / 0 / 0 |
| Directors | Four independent non-executive directors |
| AIFM / Investment Manager | Schroder Unit Trusts Limited (AIFM); portfolio management by Schroders Capital / Schroder Investment Management Limited |
| Portfolio Managers | Tim Creed and Peraveenan (Pav) Sriharan (Schroders Capital) |
| Company Secretary | Schroder Investment Management Limited |
| Depositary and custodian | J.P. Morgan Europe Limited (from 5 September 2025) |
| Auditor | Johnston Carmichael LLP (appointed January 2026 for the year ending 31 March 2026, following a competitive tender) |
| Ultimate parent of manager | Schroders plc, acquired by Nuveen (TIAA) with completion on 1 October 2026 |
| Market capitalisation (current) | c.£51.7m–£54.7m (73.9m shares × 70.00p–74.00p; most recent price observations 70.00p on 17 July 2026 and 74.00p per Stockopedia, retrieved October 2026, which states market cap of £54.69m) |
| Latest audited NAV | £79.2m / 107.24p per share at 31 March 2026 |
| Discount to NAV | 34.7% at 31 March 2026; c.36.4% on 20 May 2026 using daily NAV of 110.89p (AJ Bell) |
| Ongoing charges | 1.29% (FY2026); 1.50% (FY2025); 1.40% (FY2024) |
| Dividend | None; dividends paid only to the extent required to maintain investment-trust status |
| Gearing policy | Maximum 10% of NAV at drawdown; no borrowing disclosed |
| Website | www.schroders.com/sbo |
| Continuation mechanism | Managed wind-down resolution to be put to shareholders in Q1 2027, passing if any single vote is cast in favour (enhanced voting) |
The identification details supplied ("Schroder British Opportunities Ltd", Country: Austria, LSE, ticker SBO.L) partially match. The listed entity behind ticker SBO on the London Stock Exchange is Schroder British Opportunities Trust plc, a UK public limited company and approved UK investment trust. It is not an Austrian entity and is a "plc", not a "Ltd". The "Austria" tag in the source list appears to be a data error. One portfolio holding (Cera Care) is held via a Luxembourg vehicle and the liquidity fund is Luxembourg-domiciled, but the issuer itself is UK-domiciled.
Schroder British Opportunities Trust plc is a sub-£100m London-listed investment trust that offers retail and institutional investors access to minority stakes in established, EBITDA-positive, predominantly UK private companies, sourced through Schroders Capital's European private-equity network of more than 100 specialist general-partner relationships. Launched in December 2020 as a hybrid public/private UK growth vehicle, it abandoned its quoted-equity sleeve in 2025 after that sleeve detracted from returns, and since 31 May 2026 has been a pure private-equity portfolio of twelve holdings, heavily tilted towards vertical software, insurance-related technology and tech-enabled services (Expana, Arrive, Pirum, CFC Underwriting, Cera Care, CSL, Acturis, Culligan, JMG, Rapyd). Portfolio companies are growing sales and EBITDA in the mid-teens with c.37% average EBITDA margins, yet the shares trade at a persistent discount of roughly 35% to NAV. The decisive near-term event is a shareholder vote in Q1 2027 that is structurally biased towards an orderly multi-year managed wind-down.
---
### The company's own description (paraphrased from the FY2026 Annual Report)
The company describes its purpose as giving all investors access to high-quality, predominantly UK-based private companies focused on sustainable growth, with the Board prioritising long-term capital growth over dividend income. Its formal investment objective, adopted at the General Meeting of 9 September 2025, is to deliver long-term total returns over the life of the company by investing in a diversified portfolio of private equity investments in predominantly UK companies. "UK Companies" is defined broadly to include businesses incorporated, headquartered or principally active in the UK, and overseas-headquartered businesses deriving a significant share of revenues or profits from the UK.
The company carries on business as an externally managed investment trust. It has outsourced all operations: the Board sets strategy and oversees service providers; the Investment Manager implements the investment process, manages risk, values unquoted holdings (subject to Board Valuations Committee oversight) and markets the shares.
### Investment policy parameters (FY2026 Annual Report)
| Parameter | Policy |
|---|---|
| Eligible instruments | (a) unlisted shares, LP interests and equivalents; (b) warrants, options, convertibles and other rights over (a); (c) preference shares; (d) debt instruments including loan stock, PIK and shareholder loans. Focus expected on (a) and (b) |
| Target company size | Equity value c.£50m to £2bn at time of initial investment |
| Single-company limit | Max 15% of NAV per investee company (at commitment) |
| Non-UK limit | Max 20% of NAV in companies that are not UK Companies |
| Control | No controlling stakes; max 20% of enterprise value of any investee |
| Listed funds | Max 10% of gross assets in listed closed-ended funds (15% absolute cap for investment companies on the Official List) |
| Gearing | Max 10% of NAV at drawdown |
| Derivatives | Permitted for investment, efficient portfolio management and currency hedging; non-sterling exposure normally unhedged |
| Cash | No limit; may hold significant cash and money market funds |
| Look-through | Restrictions applied on a look-through basis for SPVs |
### Business and "revenue" model
| Revenue/return source | Characterisation | Materiality |
|---|---|---|
| Unrealised gains/losses on unquoted holdings | Quarterly fair-value revaluations by Schroders Capital using EBITDA/gross-profit multiples and recent transaction prices | Dominant driver of NAV |
| Realised gains and distributions | E.g. £1.2m distribution from CFC Underwriting (FY2026); £2.4m Waterlogic distribution (FY2023) | Episodic |
| Quoted equity gains/losses | Daily mark-to-market; fully exited by 31 May 2026 | Historical only |
| Money-market and interest income | Schroder Special Situations – Sterling Liquidity Plus Fund (£8.6m at 31 March 2026) | Small |
| Dividend income | Historically from quoted holdings | Now negligible |
As an investment trust, SBO's economic model is the generation of capital gains (and occasional distributions) from its portfolio, net of management fees, performance fees and operating costs. Its accounting "revenue" consists of investment income (dividends from quoted holdings historically, interest and money-market income); the company has consistently reported a net revenue loss per share (for example, –0.77p for the nine months to 31 March 2022 and –0.86p for FY2023), reflecting the low-yielding, capital-growth nature of the portfolio. Total return is overwhelmingly driven by capital movements in unquoted valuations.
**Product vs service vs subscription vs licensing mix:** not applicable. The trust's look-through exposure is, however, weighted to recurring-revenue software and subscription/data businesses (Expana, Pirum, Acturis, Arrive) and tech-enabled services (Cera, CSL, Rapyd, JMG, CFC).
### Value-chain position and fee structure
| Fee element | Terms (as disclosed) |
|---|---|
| Management fee | Calculated on quarterly cum-income NAV (platform summary of Annual Report terms) |
| Performance fee | 15% of the amount by which the Private Equity Portfolio Total Return over a calculation period exceeds a 10% p.a. hurdle (Hargreaves Lansdown summary of AIFM agreement); terms amended during FY2026 per the Section 172 report |
| Performance fee history | £1.67m accrued at 31 March 2024 and 31 March 2025, paid during FY2026; no performance fee accrued in FY2026 |
SBO sits as a listed minority co-investor alongside lead private-equity sponsors. Most holdings are accessed through intermediary vehicles managed by third-party GPs (Synova, Bowmark, Vitruvian, Astorg, EPIC/EQT-linked fund, Target Global, ECI, ILC, Agilitas), meaning SBO is typically a co-investor rather than the lead sponsor.
### Customer types and end-markets
| End-market (look-through) | Holdings |
|---|---|
| Vertical software / data | Expana (food commodity pricing), Pirum (securities-finance post-trade), Acturis (insurance SaaS), Arrive (parking/mobility platform) |
| Specialist insurance | CFC Underwriting |
| Insurance broking (financial services) | JMG Group |
| Health care technology / home care | Cera Care |
| IT services / IoT connectivity | CSL |
| Payments infrastructure | Rapyd Financial Network |
| Water treatment / consumer services | Culligan |
| HR technology / workforce solutions | HeadFirst Global |
| Education and training | Learning Curve Group |
The trust's "customers" are its shareholders: UK retail investors via platforms (the shares are ISA/SIPP-eligible), wealth managers and institutional holders. Look-through end-markets are summarised below (FY2026 Annual Report sector classifications).
### Independent characterisation
SBO is best understood as a small, concentrated, closed-end feeder into Schroders Capital's UK/European growth and small/mid-buyout co-investment programme, wrapped in a listed structure with a built-in exit date. Its distinguishing features versus larger listed private-equity trusts are: (i) direct/co-investment exposure rather than fund-of-funds; (ii) a UK mandate; (iii) a very small asset base (c.£79m NAV), which inflates the ongoing-charge ratio and limits liquidity; and (iv) a governance structure that makes a managed wind-down the default outcome in 2027. The 2025 strategy pivot effectively converted it from a "public-private growth fund" into a run-off-ready private-equity portfolio.